A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder

D. G. Baker; B. I. Diamond; G. Gillette; M. Hamner; D. Katzelnick; T. Keller; T. A. Mellman; E. Pontius; M. Rosenthal; P. Tucker; B. A. vander Kolk; R. Katz

doi:10.1007/BF02246271

A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder

D. G. Baker, B. I. Diamond, G. Gillette, M. Hamner, D. Katzelnick, T. Keller, T. A. Mellman, E. Pontius, M. Rosenthal, P. Tucker, B. A. vander Kolk, R. Katz

Psychiatry and Psychology

Research output: Contribution to journal › Article › peer-review

112 Scopus citations

Abstract

A large multi-center, double-blind, parallel trial to assess the efficacy of brofaromine in the treatment of post traumatic stress disorder (PTSD) failed to show a significant difference between the brofaromine and placebo treatment groups. The placebo response rate in this study was higher than that in previously published double-blind, placebo-controlled studies of PTSD.

Original language	English (US)
Pages (from-to)	386-389
Number of pages	4
Journal	Psychopharmacology
Volume	122
Issue number	4
DOIs	https://doi.org/10.1007/BF02246271
State	Published - Dec 1995

Keywords

Brofaromine
MAOI
PTSD
Psychopharmacology

ASJC Scopus subject areas

Pharmacology

Access to Document

10.1007/BF02246271

Cite this

Baker, D. G., Diamond, B. I., Gillette, G., Hamner, M., Katzelnick, D., Keller, T., Mellman, T. A., Pontius, E., Rosenthal, M., Tucker, P., vander Kolk, B. A., & Katz, R. (1995). A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology, 122(4), 386-389. https://doi.org/10.1007/BF02246271

Baker, DG, Diamond, BI, Gillette, G, Hamner, M, Katzelnick, D, Keller, T, Mellman, TA, Pontius, E, Rosenthal, M, Tucker, P, vander Kolk, BA & Katz, R 1995, 'A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder', Psychopharmacology, vol. 122, no. 4, pp. 386-389. https://doi.org/10.1007/BF02246271

@article{e6aaeb52d62e4d9e9494fb41cfa7c843,

title = "A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder",

abstract = "A large multi-center, double-blind, parallel trial to assess the efficacy of brofaromine in the treatment of post traumatic stress disorder (PTSD) failed to show a significant difference between the brofaromine and placebo treatment groups. The placebo response rate in this study was higher than that in previously published double-blind, placebo-controlled studies of PTSD.",

keywords = "Brofaromine, MAOI, PTSD, Psychopharmacology",

author = "Baker, {D. G.} and Diamond, {B. I.} and G. Gillette and M. Hamner and D. Katzelnick and T. Keller and Mellman, {T. A.} and E. Pontius and M. Rosenthal and P. Tucker and {vander Kolk}, {B. A.} and R. Katz",

year = "1995",

month = dec,

doi = "10.1007/BF02246271",

language = "English (US)",

volume = "122",

pages = "386--389",

journal = "Psychopharmacology",

issn = "0033-3158",

publisher = "Springer Verlag",

number = "4",

}

TY - JOUR

T1 - A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder

AU - Baker, D. G.

AU - Diamond, B. I.

AU - Gillette, G.

AU - Hamner, M.

AU - Katzelnick, D.

AU - Keller, T.

AU - Mellman, T. A.

AU - Pontius, E.

AU - Rosenthal, M.

AU - Tucker, P.

AU - vander Kolk, B. A.

AU - Katz, R.

PY - 1995/12

Y1 - 1995/12

N2 - A large multi-center, double-blind, parallel trial to assess the efficacy of brofaromine in the treatment of post traumatic stress disorder (PTSD) failed to show a significant difference between the brofaromine and placebo treatment groups. The placebo response rate in this study was higher than that in previously published double-blind, placebo-controlled studies of PTSD.

AB - A large multi-center, double-blind, parallel trial to assess the efficacy of brofaromine in the treatment of post traumatic stress disorder (PTSD) failed to show a significant difference between the brofaromine and placebo treatment groups. The placebo response rate in this study was higher than that in previously published double-blind, placebo-controlled studies of PTSD.

KW - Brofaromine

KW - MAOI

KW - PTSD

KW - Psychopharmacology

UR - http://www.scopus.com/inward/record.url?scp=9044249718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9044249718&partnerID=8YFLogxK

U2 - 10.1007/BF02246271

DO - 10.1007/BF02246271

M3 - Article

C2 - 8657838

AN - SCOPUS:9044249718

SN - 0033-3158

VL - 122

SP - 386

EP - 389

JO - Psychopharmacology

JF - Psychopharmacology

IS - 4

ER -

A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this